Promimic AB
STO:PRO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Promimic AB
Promimic AB operates as a holding company that develops and markets implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2022-04-29. The firm manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The firm operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
Promimic AB operates as a holding company that develops and markets implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2022-04-29. The firm manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The firm operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
